FIELD: medicine, gastroenterology.
SUBSTANCE: one should simultaneously introduce perorally Essentiale at the dosage of 1 capsule twice daily and Liproxol at the dosage of 2 g twice daily, therapy course should last for about 21-28 d. Combined application of well-known concrete hepatoprotectors in case of chronic hepatitis of different etiology enables to considerably decrease the dosages of the above-mentioned preparations at keeping high efficiency of therapy.
EFFECT: higher efficiency of therapy.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF CHRONIC HEPATITIS | 2005 |
|
RU2286792C1 |
METHOD OF TREATING CHRONIC HEPATITIS | 1998 |
|
RU2175237C2 |
METHOD FOR TREATING CHRONIC HEPATITIS | 1995 |
|
RU2112535C1 |
METHOD FOR PREDICTING CIRRHOSIS AT CHRONIC VIRAL HEPATITIS | 2003 |
|
RU2244306C1 |
USING ACIZOL AS HEPATOPROTECTING AGENT | 2004 |
|
RU2260427C1 |
METHOD FOR PREDICTION OF FATAL OUTCOME IN PATIENTS SUFFERING FROM VIRAL AND ALCOHOLIC HEPATIC CIRRHOSIS | 2008 |
|
RU2373533C1 |
METHOD FOR TREATMENT OF ALCOHOLIC LIVER DISEASES | 2004 |
|
RU2286785C2 |
AGENT "EXTRAHOLM" FOR SUGAR CONTROL IN PATIENTS SUFFERING FROM DIABETES COMPLICATED BY HEPATOPATHY AND BILE PASSAGES DISORDERS | 2007 |
|
RU2360695C1 |
METHOD FOR EVALUATING FUNCTIONAL HEPATIC STATE IN PATIENTS WITH CHRONIC HEPATITIS AND CIRRHOSIS | 1999 |
|
RU2194280C2 |
METHOD OF TREATING DRUG-INDUCED LIVER INJURY IN CHILDREN SUFFERING FROM TUBERCULOSIS | 2011 |
|
RU2473346C1 |
Authors
Dates
2006-08-27—Published
2005-03-05—Filed